Cargando…
Factors Predicting Long-term Outcome and the Need for Surgery in Graves Orbitopathy: Extended Follow-up From the CIRTED Trial
: Graves orbitopathy is both disabling and disfiguring. Medical therapies to reduce inflammation are widely used, but there is limited trial data beyond 18 months of follow-up. METHODS: Three-year follow-up of a subset of the CIRTED trial (N = 68), which randomized patients to receive high-dose ora...
Autores principales: | Taylor, Peter, Rajendram, Rathie, Hanna, Stephanie, Wilson, Victoria, Pell, Julie, Li, Chunhei, Cook, Anne, Gattamaneni, Rao, Plowman, Nicholas, Jackson, Sue, Hills, Robert, French, Robert, Uddin, Jimmy M, Lee, Richard W J, Dayan, Colin M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505546/ https://www.ncbi.nlm.nih.gov/pubmed/36971324 http://dx.doi.org/10.1210/clinem/dgad084 |
Ejemplares similares
-
Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: A multi-centre, double-masked, factorial randomised controlled trial
por: Rajendram, Rathie, et al.
Publicado: (2008) -
Orbital Signaling in Graves’ Orbitopathy
por: Draman, Mohd Shazli, et al.
Publicado: (2021) -
SAT-554 Teprotumumab in Graves' Orbitopathy: Extended Outcome Analyses
por: Kahaly, George, et al.
Publicado: (2019) -
Graves' Orbitopathy
por: Hiromatsu, Yuji, et al.
Publicado: (2015) -
Asymmetric Graves’ Orbitopathy
por: Panagiotou, Grigorios, et al.
Publicado: (2020)